Divi’s Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold?

Divi’s Labs surged 6% after reporting a 64% YoY profit jump in Q3FY25. Revenue rose 25% YoY to Rs 2,319 crore. Goldman Sachs stays Neutral (target: Rs 5,925), while Nuvama maintains Buy (target: Rs 6,830) citing strong growth potential.

More To Explore

5 world market themes for the week ahead

An important week is upcoming with central banks like the Federal Reserve and European Central Bank making policy decisions. Major companies, including Alphabet, Amazon, and